# China’s Junshi Nabs FDA Approval in Rare Success for US Foray
**FDA Update**

**2023-10-28 03:26**

**https://www.ainvest.com/news/china-s-junshi-nabs-fda-approval-in-rare-success-for-us-foray-231010008e5a1835cc39bdc3/**

The US Food and Drug Administration has cleared the first China-developed cancer drug similar to Merck & Co.’s blockbuster therapy Keytruda, making it a rare success among Chinese biotechnology firms seeking to break into the world’s most lucrative market.